期刊文献+

非布司他的合成 被引量:3

Synthesis of Febuxostat
下载PDF
导出
摘要 目的合成非布司他。方法以2-(3-甲酰基-4-羟基苯基)-4-甲基-噻唑-5-甲酸乙酯为起始原料,经醚化、氰化、水解制得目标化合物。结果目标化合物经核磁共振氢谱、质谱、红外光谱及元素分析等确证其化学结构,总收率46.1%。结论本工艺反应条件温和,成本较低,环境污染小,产品纯度高,质量容易控制。 Objective To synthesize febuxostat. Methods Starting from ethyl 2-(3-formyl-4-hydroxyphenyl)- 4-methylthiazole-5-carboxylate, febuxostat was prepared via a series of steps including etherification, cyanide, hydrolysis. Results The structure of febuxostat was verified by 1HNMR, MS, IR and element analysis. The total yield of febuxostat was 46.1%. Conclusion In the synthesis of febuxostat, reaction condition is temperate, the cost is low, the environmental pollution is small, the product purity is high, and the product quality is easy to control.
出处 《食品与药品》 CAS 2012年第7期263-265,共3页 Food and Drug
关键词 非布司他 合成 痛风 febuxostat synthesis uarthritis
  • 相关文献

参考文献9

二级参考文献57

  • 1张媛.抗痛风药Febuxostat[J].药学进展,2005,29(3):141-142. 被引量:8
  • 2王春辉,李松.黄嘌呤氧化酶抑制剂的研究进展[J].国外医学(药学分册),2006,33(5):351-353. 被引量:17
  • 3YAMAMOTO T. Development of antihyperuricemic candidates[J]. Nippon Rinsho, 2003, 61 ( S1 ) : 209 - 212. 被引量:1
  • 4TAKANO Y, HASE-AOKI K, HORIUCHI H, et al. Selectivity of febuxostat, a novel nonpurine inhibitor of xanthine oxldase/xanthine dehydyogenase[J]. Life Sci, 2005, 76(16) : 1835 - 1847. 被引量:1
  • 5BECKER M A, SCHUMACHER H R Jr, WORTMANN R L. Febuxostat compared with aUopurinol in patients with hyperurlcemia and gout [ J ]. N Engl J IVied, 2005, 353(23) :2450 - 2461. 被引量:1
  • 6BECKER M A, SCHUMACHER H R Jr, WORTMANN R L. Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a 28-day, multicenter, phase Ⅱ, randomized, double-blind, placebo controlled dose-response clinical trial examining safety and efficacy in patients with gout [ J ]. Arthritis Rheum, 2005, 52(3) :916 - 923. 被引量:1
  • 7POHAR S, MURPHY G. Febuxostat for prevention of gout attacks [ J ]. Issues Emerg Health Technol, 2006, 87(8) : 1 - 4. 被引量:1
  • 8TAYLOR W :j, SCHUMACHER H R :Jr. Assessment of outcome in clinical trials of gout-a review of current measures [ :J ]. Rheumatology, 2007, 46 ( 12 ) : 1751 - 1756. 被引量:1
  • 9BRYAN T, EMMERSON M D. The treatment of gout[J]. Drug Ther, 1996, 334(7) : 445 - 451. 被引量:1
  • 10VERGE J P, ROFFEY P. Antiprotozoal thiazoles. 2- (5-nitro-2-thienyl)-thiazoles[J] .J Med Chem, 1975, 18(8) :794. 被引量:1

共引文献35

同被引文献29

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部